// App-Quantinova.ai

BSH19‐EP‐025 : Responses to BTK inhibitors in mantle cell lymphoma post allogeneic stem cell transplant

Researchers

Presenter

  • S. Wharin

Principal Investigators

  • A. Tsoulkani

  • H. Walter

  • A. Hunter

  • K. Hodgson

  • R. Lewin

  • M. Dyer

  • M. Martin

  • F. Miall

Medical Centers

  • Rheumatology, University Hospitals of Leicester, Leicester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

  • Mantle cell lymphoma

  • Lymphomas

Biomarkers

  • Bruton tyrosine kinase

Drug/Treatment

  • Entospletinib

  • ACP-196

  • Tirabrutinib

  • fludarabine tablet

  • Venetoclax

  • Ibrutinib

  • Melphalan

  • Rituximab

  • Alemtuzumab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved